IFM Investors Pty Ltd Has $15.28 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

IFM Investors Pty Ltd boosted its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 92,781 shares of the company's stock after buying an additional 8,570 shares during the period. IFM Investors Pty Ltd's holdings in Zoetis were worth $15,276,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of ZTS. Norges Bank bought a new stake in Zoetis in the fourth quarter valued at approximately $824,321,000. Wellington Management Group LLP increased its stake in Zoetis by 78.5% in the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock valued at $1,133,755,000 after purchasing an additional 3,059,255 shares in the last quarter. Sarasin & Partners LLP bought a new stake in Zoetis in the first quarter valued at approximately $339,111,000. GAMMA Investing LLC increased its stake in Zoetis by 14,731.3% in the first quarter. GAMMA Investing LLC now owns 1,759,285 shares of the company's stock valued at $289,666,000 after purchasing an additional 1,747,423 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Zoetis during the fourth quarter worth $196,651,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ZTS has been the subject of several research reports. Piper Sandler increased their price objective on shares of Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. UBS Group lowered their price objective on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Finally, Stifel Nicolaus downgraded shares of Zoetis from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $212.13.

Zoetis Stock Up 0.4%

Zoetis stock traded up $0.67 during mid-day trading on Tuesday, reaching $157.72. The company's stock had a trading volume of 2,885,127 shares, compared to its average volume of 2,578,492. The company has a market capitalization of $70.22 billion, a price-to-earnings ratio of 28.32, a price-to-earnings-growth ratio of 2.60 and a beta of 0.91. Zoetis Inc. has a 12 month low of $139.70 and a 12 month high of $200.33. The business's 50 day simple moving average is $161.27 and its 200 day simple moving average is $161.99. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.04 and a current ratio of 1.74.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. The business had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a net margin of 27.12% and a return on equity of 55.48%. The firm's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.38 earnings per share. As a group, research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date is Friday, July 18th. Zoetis's dividend payout ratio is currently 35.91%.

Insider Activity

In other news, EVP Roxanne Lagano sold 652 shares of the company's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the sale, the executive vice president owned 15,129 shares in the company, valued at $2,571,930. This represents a 4.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.16% of the stock is currently owned by corporate insiders.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.